amicus
therapeutics
announce
third
quarter
financial
results
november
cranbury
globe
newswire
amicus
therapeutics
nasdaq
fold
today
announced
company
host
conference
call
live
audio
webcast
thursday
november
et
discuss
financial
results
third
quarter
ended
september
interested
participants
investors
may
access
conference
call
dialing
canada
international
conference
id
live
audio
webcast
related
presentation
materials
also
accessed
via
investors
section
amicus
therapeutics
corporate
website
web
participants
encouraged
register
website
minutes
prior
start
call
replay
call
available
seven
days
beginning
et
access
numbers
replay
canada
international
conference
id
amicus
therapeutics
amicus
therapeutics
nasdaq
fold
global
biotechnology
company
focused
discovering
developing
delivering
novel
medicines
people
living
rare
metabolic
diseases
extraordinary
patient
focus
amicus
therapeutics
committed
advancing
expanding
robust
pipeline
medicines
rare
metabolic
diseases
information
please
visit
company
website
follow
twitter
linkedin
contact
investors
amicus
therapeutics
andrew
faughnan
director
investor
relations
afaughnan
media
amicus
therapeutics
diana
moore
head
global
corporate
communications
dmoore
